权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Endocrine Regulation of Alcohol Intake

酒精摄入的内分泌调节

基本信息

批准号：
10083683
负责人：
Matthew Joseph Potthoff
金额：
$ 43.72万
依托单位：
UNIVERSITY OF IOWA
依托单位国家：
美国
项目类别：
财政年份：
2020
资助国家：
美国
起止时间：
2020-01-10 至 2024-12-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10083683
关键词：
Acute Address Adolescent and Young Adult Adult Affect Alcohol consumption Alcoholic Intoxication Alcohols Amygdaloid structure Animal Model Automobile Driving Behavior Behavioral Biological Assay Brain Cardiovascular Diseases Cells Chronic Consummatory Behavior Consumption Data Diagnosis Dissection Dopamine Drug usage Economic Burden Endocrine Enterobacteria phage P1 Cre recombinase Ethanol Etiology Feedback Genes Genetic Polymorphism Genetic Variation Glutamates Goals Grant Health Care Costs Healthcare Heavy Drinking Hormonal Hormones Human Individual Knock-out Knockout Mice Liver Malignant Neoplasms Measures Mediating Metabolic Metabolic syndrome Metabolism Modeling Mus National Institute on Alcohol Abuse and Alcoholism Neuraxis Neurons Nucleus Accumbens Pathologic Pathway interactions Peripheral Pharmacologic Substance Pharmacology Physiological Physiology Population Prevalence Production Regulation Rewards Role Series Signal Pathway Signal Transduction Single Nucleotide Polymorphism Synaptic Transmission System Techniques Testing Therapeutic Time Tissues United States Ventral Tegmental Area Work alcohol abuse therapy alcohol exposure alcohol use disorder base binge drinking cancer risk designer receptors exclusively activated by designer drugs fibroblast growth factor 21 genomic locus improved in vivo innovation insight mesolimbic system mouse model neural circuit new therapeutic target novel preference prevent productivity loss promoter receptor targeted treatment therapeutic target tool

项目摘要

PROJECT SUMMARY / ABSTRACT In the United States, alcohol use disorder (AUD) affects ~15% of adults with the prevalence of binge drinking on the rise in adolescents and young adults. AUD represents a major issue to healthcare given that chronic excessive alcohol consumption in humans is associated with cardiovascular disease, metabolic syndrome, and cancer while acute alcohol intoxication can prove lethal. Economically, AUD represents a massive burden due to loss of productivity and associated healthcare costs. Recently, the endocrine hormone fibroblast growth factor 21 (FGF21), known for its potent metabolic effects, was found to significantly reduce alcohol consumption via signaling through its obligate co-receptor, β-klotho, in the brain. Importantly, single nucleotide polymorphisms (SNPs) in both the FGF21 and β-klotho genomic loci are highly associated with increased alcohol consumption in humans. Our preliminary data demonstrates that FGF21 treatment markedly suppresses alcohol consumption in mice previous subjected to chronic alcohol exposure. Furthermore, excessive alcohol consumption promotes FGF21 secretion from the liver representing a homeostatic feedback loop to regulate alcohol consumption. However, the mechanism of FGF21 action in the brain and the neuronal target(s) for these effects has not been determined. The overall goal of this proposal is to identify the neural circuit(s) regulating FGF21-mediated suppression of alcohol intake. The aims of this grant are to 1) determine the direct neuronal target(s) of FGF21 in the CNS mediating inhibition of alcohol intake, and 2) determine how FGF21 modulates reward circuits to regulate alcohol intake and preference. To accomplish these aims, we have generated novel animal models and tools to examine these experimental aims. These studies will provide new fundamental insights into the regulation of alcohol intake by peripheral endocrine signals acting on the central nervous system. In addition, these studies may identify novel therapeutic targets for the treatment of AUD.

项目摘要/摘要